{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coumarin", "C\u2013N coupling", "EGFR", "Knoevenagel condensation", "VEGFR-2", "metal-free domino reaction"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35821884", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1080/17518253.2021.1981462"], "Journal": {"ISSN": "1751-8253", "JournalIssue": {"Volume": "14", "Issue": "4", "PubDate": {"Year": "2021"}}, "Title": "Green chemistry letters and reviews", "ISOAbbreviation": "Green Chem Lett Rev"}, "ArticleTitle": "Metal-free domino amination-Knoevenagel condensation approach to access new coumarins as potent nanomolar inhibitors of VEGFR-2 and EGFR.", "Pagination": {"StartPage": "578", "EndPage": "599", "MedlinePgn": "578-599"}, "Abstract": {"AbstractText": ["A metal-free, atom-economy and simple work-up domino amination-Knoevenagel condensation approach to construct new coumarin analogous (<b>4a-f</b> and <b>8a-e</b>) was described. Further, new formyl (<b>5a,d-f</b>) and nitro (<b>9a,d-f</b>) coumarin derivatives were synthesized via C-N coupling reaction of various cyclic secondary amines and 4-chloro-3-(formyl-/nitro)coumarins (<b>1a,c</b>), respectively. The confirmed compounds were screened for their <i>in vitro</i> anti-proliferative activity against KB-3-1, A549 and PC3 human cancer cell lines using resazurin cellular-based assay. Among them, coumarin derivatives <b>4e</b> and <b>8e</b> displayed the best anti-cervical cancer potency (KB-3-1) with IC<sub>50</sub> values of 15.5 \u00b1 3.54 and 21 \u00b1 4.24 \u03bcM, respectively. Also, <b>4e</b> showed the most promising cytotoxicity toward A549 with IC<sub>50</sub> value of 12.94 \u00b1 1.51 \u03bcM. As well, <b>9d</b> presented a more significant impact of potency against PC3 with IC<sub>50</sub> 7.31 \u00b1 0.48 \u03bcM. Moreover, <b>8d</b> manifested selectivity against PC3 (IC<sub>50</sub> = 20.16 \u00b1 0.07 \u03bcM), while <b>8e</b> was selective toward KB-3-1 cell line (IC<sub>50</sub> = 21 \u00b1 4.24 \u03bcM). Matching with docking profile, the enzymatic assay divulged that <b>8e</b> is a dual potent single-digit nanomolar inhibitor of VEGFR-2 and EGFR with IC<sub>50</sub> values of 24.67 nM and 31.6 nM that were almost equipotent to sorafenib (31.08 nM) and erlotinib (26.79 nM), respectively."]}, "AuthorList": [{"Identifier": ["0000-0001-5570-1427"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany."}, {"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City-Cairo, Egypt."}], "LastName": "Eliwa", "ForeName": "Essam M", "Initials": "EM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany."}], "LastName": "Frese", "ForeName": "Marcel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City-Cairo, Egypt."}], "LastName": "Halawa", "ForeName": "Ahmed H", "Initials": "AH"}, {"Identifier": ["0000-0002-7370-0142"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biology Unit, Central Laboratory for Pharmaceutical and Drug Industries Research Division, Chemistry of Medicinal Plants Department, Pharmaceutical and Drug Industries Research Division, National Research Centre Cairo, Egypt."}], "LastName": "Soltan", "ForeName": "Maha M", "Initials": "MM"}, {"Identifier": ["0000-0003-2182-8774"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Pharmaceutical Research and Innovation, University of Kentucky, Lexington, USA."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, USA."}], "LastName": "Ponomareva", "ForeName": "Larissa V", "Initials": "LV"}, {"Identifier": ["0000-0002-7148-0721"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Pharmaceutical Research and Innovation, University of Kentucky, Lexington, USA."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, USA."}], "LastName": "Thorson", "ForeName": "Jon S", "Initials": "JS"}, {"Identifier": ["0000-0001-7638-4942"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Pharmaceutical Research and Innovation, University of Kentucky, Lexington, USA."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, USA."}], "LastName": "Shaaban", "ForeName": "Khaled A", "Initials": "KA"}, {"Identifier": ["0000-0001-9281-2505"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany."}, {"Identifier": [], "Affiliation": "Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki-Cairo, Egypt."}], "LastName": "Shaaban", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": ["0000-0001-7019-411X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City-Cairo, Egypt."}], "LastName": "El-Agrody", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-0309-2655"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany."}], "LastName": "Sewald", "ForeName": "Norbert", "Initials": "N"}], "GrantList": [{"GrantID": "P20 GM130456", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "R01 GM115261", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "UL1 TR000117", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}, {"GrantID": "UL1 TR001998", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Green Chem Lett Rev", "NlmUniqueID": "101471709", "ISSNLinking": "1751-7192"}, "CoiStatement": "Disclosure statement No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Avendano C; Carlos Menendez J Medicinal Chemistry of Anticancer Drugs, 1st ed.; Elsevier: 2008; pp 1\u20137."}, {"Citation": "Boraei ATA; Ashour HK; El-Tamany E-SH; Abdelmoaty N; El-Falouji AI; Gomaa MS Design and Synthesis of New Phthalazine-Based Derivatives as Potential EGFR Inhibitors for the Treatment of Hepatocellular Carcinoma. Bioorg. Chem 2019, 85, 293\u2013307. doi: 10.1016/j.bioorg.2018.12.039.", "ArticleIdList": ["10.1016/j.bioorg.2018.12.039", "30654221"]}, {"Citation": "Amin KM; Barsoum FF; Awadallah FM; Mohamed NE Identification of New Potent Phthalazine Derivatives with VEGFR-2 and EGFR Kinase Inhibitory Activity. Eur. J. Med. Chem 2016, 123, 191\u2013201. doi: 10.1016/j.ejmech.2016.07.049.", "ArticleIdList": ["10.1016/j.ejmech.2016.07.049", "27484508"]}, {"Citation": "Zhang H-Q;Gong F-H; Fei H-J; Li C-G;Zhang C; Wang Y-J; Xu Y-G; Hu R; Suna L-P Design and Discovery of 4-Anilinoquinazoline-Acylamino Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors. Eur. J. Med. Chem 2016, 109, 371\u2013379. doi: 10.1016/j.ejmech.2015.12.032.", "ArticleIdList": ["10.1016/j.ejmech.2015.12.032", "26826581"]}, {"Citation": "Modi SJ; Kulkarni VM Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective. Medicine in Drug Discovery 2019, 2, 100009. doi: 10.1016/j.medidd.2019.100009.", "ArticleIdList": ["10.1016/j.medidd.2019.100009"]}, {"Citation": "Sordella R; Bell DW; Haber DA; Settleman J Gefitinib-sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways. Science 2004, 305, 1163\u20131167. doi: 10.1126/science.1101637.", "ArticleIdList": ["10.1126/science.1101637", "15284455"]}, {"Citation": "El-Metwally SA; Abou-El-Regal MM; Eissa IH; Mehany ABM; Mahdy HA; Elkady H; Elwan A; Elkaeed EB Discovery of Thieno[2,3-d]Pyrimidine-Based Derivatives as Potent VEGFR-2 Kinase Inhibitors and Anti-Cancer Agents. Bioorg. Chem 2021, 112, 104947. doi: 10.1016/j.bioorg.2021.104947.", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "Alanazi MM; Mahdy HA; Alsaif NA; Obaidullah AJ; Alkahtani HM; Al-Mehizia AA; Alsubaie SM; Dahab MA; Eissa IH New bis([1,2,4]Triazolo)[4,3-a:3\u2032,4\u2032-c]Quinoxaline Derivatives as VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, in Silico Studies, and Anticancer Evaluation. Bioorg. Chem 2021, 112, 104949. doi: 10.1016/j.bioorg.2021.104949.", "ArticleIdList": ["10.1016/j.bioorg.2021.104949", "34023640"]}, {"Citation": "Eissa IH; Ibrahim MK; Metwaly AM; Belal A; Mehany ABM; Abdelhady AA; Elhendawy MA; Radwan MM; ElSohly MA; Mahdy HA Design, Molecular Docking, in Vitro, and in Vivo Studies of new Quinazolin-4(3H)-Ones as VEGFR-2 Inhibitors with Potential Activity Against Hepatocellular Carcinoma. Bioorg. Chem 2021, 707, 104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Aziz MA; Serya RAT; Lasheen DS; Abdel-Aziz AK; Esmat A; Mansour AM; Singab AB; Abouzid KAM Discovery of Potent VEGFR-2 Inhibitors Based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents. Sci. Rep 2016, 6, 24460. doi: 10.1038/srep24460.", "ArticleIdList": ["10.1038/srep24460", "PMC4832243", "27080011"]}, {"Citation": "Saleh NM; Abdel-Rahman AA-H; Omar AM; Khalifa MM; El-Adl K Pyridine-Derived VEGFR-2 Inhibitors: Rational Design, Synthesis, Anticancer Evaluations, in Silico ADMET Profile, and Molecular Docking. Arch. Pharm 2021,354, 2100085. doi: 10.1002/ardp.202100085.", "ArticleIdList": ["10.1002/ardp.202100085", "33948983"]}, {"Citation": "Gabera AA; Bayoumia AH; El-morsya AM; Sherbinya FF; Mehanyb ABM; Eissa IH Design, Synthesis and Anticancer Evaluation of 1H-Pyrazolo[3,4-d] Pyrimidine Derivatives as Potent EGFRWT and EGFRT790M Inhibitors and Apoptosis Inducers. Bioorg. Chem 2018, 80, 375\u2013395. doi: 10.1016/j.bioorg.2018.06.017.", "ArticleIdList": ["10.1016/j.bioorg.2018.06.017", "29986185"]}, {"Citation": "Kurt BZ; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT Synthesis of Coumarin-Sulfonamide Derivatives and Determination of Their Cytotoxicity, Carbonic Anhydrase Inhibitory and Molecular Docking Studies. Eur. J. Med. Chem 2019, 783, 111702. doi: 10.1016/j.ejmech.2019.111702.", "ArticleIdList": ["10.1016/j.ejmech.2019.111702", "31542715"]}, {"Citation": "Wang Z-C; Qin Y-J; Wang P-F; Yang Y-A; Wen Q; Zhang X; Qiu H-Y; Duan Y-T; Wang Y-T; Sang Y-L; Zhu H-L Sulfonamides Containing Coumarin Moieties Selectively and Potently Inhibit Carbonic Anhydrases II and IX: Design, Synthesis, Inhibitory Activity and 3D-QSAR Analysis. Eur. J. Med. Chem 2013, 66, 1\u201311. doi: 10.1016/j.ejmech.2013.04.035.", "ArticleIdList": ["10.1016/j.ejmech.2013.04.035", "23777898"]}, {"Citation": "Bubols GB; Vianna DR; Medina-Remon A; Poser GV; Lamuela-Raventos RM, Eifler-Lima VL, et al. The Antioxidant Activity of Coumarins and Flavonoids. Mini Rev. Med. Chem 2013, 73, 318\u2013334.", "ArticleIdList": ["22876957"]}, {"Citation": "Matos MJ; Vazquez-Rodriguez S; Santana L; Uriarte E; Fuentes-Edfuf C, Santos Y, et al. Synthesis and Structure-Activity Relationships of Novel Amino/Nitro Substituted 3-Arylcoumarins as Antibacterial Agents. Molecules 2013, 18, 1394\u20131404. doi: 10.3390/molecules18021394.", "ArticleIdList": ["10.3390/molecules18021394", "PMC6269744", "23348993"]}, {"Citation": "Matos MJ; Vina D; Vazquez-Rodriguez S; Uriarte E; Santana L Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins as an Interesting Scaffold. Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2012, 72, 2210\u20132239. doi: 10.2174/1568026611212200008.", "ArticleIdList": ["10.2174/1568026611212200008", "23231397"]}, {"Citation": "Hwu JR; Huang W-C; Lin S-Y; Tan K-T; Hu Y-C; Shieh F-K; Bachurin SO; Ustyugov A; Tsay S-C Chikungunya Virus Inhibition by Synthetic Coumarin-Guanosine Conjugates. Eur. J. Med. Chem 2019, 166, 136\u2013143. doi: 10.1016/j.ejmech.2019.01.037.", "ArticleIdList": ["10.1016/j.ejmech.2019.01.037", "30703657"]}, {"Citation": "Kapoor S The Anti-Neoplastic Effects of Coumarin: An Emerging Concept. Cytotechnology 2013, 65, 787\u2013788. doi: 10.1007/s10616-013-9538-6.", "ArticleIdList": ["10.1007/s10616-013-9538-6", "PMC3967608", "23340967"]}, {"Citation": "Diana CGAP; Artur MSS Anticancer Natural Coumarins as Lead Compounds for the Discovery of New Drugs. Curr. Top. Med. Chem 2017, 17, 3190\u20133198.", "ArticleIdList": ["29243581"]}, {"Citation": "Emami S; Dadashpour S Current Developments of Coumarin-Based Anti-Cancer Agents in Medicinal Chemistry. Eur. J. Med. Chem 2015, 102, 611\u2013630. doi: 10.1016/j.ejmech.2015.08.033.", "ArticleIdList": ["10.1016/j.ejmech.2015.08.033", "26318068"]}, {"Citation": "Halawa AH; Abd El-Gilil SM; Bedair AH; Eliwa EM; Frese M; Sewald N; Shaaban M; El-Agrody AM Synthesis of Diverse Amide Linked Bis-indoles and Indole Derivatives Bearing Coumarin-Based Moiety: Cytotoxicity and Molecular Docking Investigations. Med. Chem. Res 2018, 27, 796\u2013806. doi: 10.1007/s00044-017-2103-7.", "ArticleIdList": ["10.1007/s00044-017-2103-7"]}, {"Citation": "Zhang L; Xu Z Coumarin-containing Hybrids and Their Anticancer Activities. Eur. J. Med. Chem 2019, 187, 111587. doi: 10.1016/j.ejmech.2019.111587.", "ArticleIdList": ["10.1016/j.ejmech.2019.111587", "31404864"]}, {"Citation": "Halawa AH; Eliwa EM; Hassan AA; Nassar HS; El-Eisawy RA; Ismail M; Frese M; Shaaban M; El-Agrody AM; Bedair AH; Sewald N Synthesis, in Vitro Cytotoxicity Activity Against the Human Cervix Carcinoma Cell Line and in Silico Computational Predictions of New 4-Arylamino-3-Nitrocoumarin Analogues. J. Mol. Struct 2020, 1200, 127047. doi: 10.1016/j.molstruc.2019.127047.", "ArticleIdList": ["10.1016/j.molstruc.2019.127047"]}, {"Citation": "Bansal Y; Sethi P; Bansal G Coumarin: A Potential Nucleus for Anti-Inflammatory Molecules. Med. Chem. Res 2013, 22, 3049\u20133060. doi: 10.1007/s00044-012-0321-6.", "ArticleIdList": ["10.1007/s00044-012-0321-6"]}, {"Citation": "Raman N; Pravin N DNA Fastening and Ripping Actions of Novel Knoevenagel Condensed Dicarboxylic Acid Complexes in Antitumor Journey. Eur. J. Med. Chem 2014, 80, 57\u201370. doi: 10.1016/j.ejmech.2014.04.032.", "ArticleIdList": ["10.1016/j.ejmech.2014.04.032", "24763363"]}, {"Citation": "Biradar JS; Sasidhar BS Solvent-free, Microwave Assisted Knoevenagel Condensation of Novel 2,5-Disubstituted Indole Analogues and Their Biological Evaluation. Eur. J. Med. Chem 2011, 46, 6112\u20136118. doi: 10.1016/j.ejmech.2011.10.004.", "ArticleIdList": ["10.1016/j.ejmech.2011.10.004", "22014995"]}, {"Citation": "Ryabukhin SV; Plaskon AS; Volochnyuk DM; Pipko SE; Shivanyuk AN; Tolmachev AA Combinatorial Knoevenagel Reactions. J. Comb. Chem 2007, 9, 1073\u20131078. doi: 10.1021/cc070073f.", "ArticleIdList": ["10.1021/cc070073f", "17900167"]}, {"Citation": "Menegatti R Green Chemistry - Aspects for the Knoevenagel Reaction, In Green Chemistry Environmentally Benign Approaches, Kidwai M, Ed.; InTech, 2012, ISBN: 978-953-51-0334-9."}, {"Citation": "Senoo T; Inoue A; Mori K Facile Synthesis of \u03c0-Conjugated Heteroaromatic Compounds via Weak-Base-Promoted Transition-Metal-Free C-N Coupling. Synthesis. (Mass) 2020, 52."}, {"Citation": "Chikayuki Y; Miyashige T; Yonekawa S; Kirita A; Matsuo N; Teramoto H; Sasaki S; Higashiyama K; Yamauchi T Transition-Metal-Free Synthesis of Pyridine Derivatives by Thermal Cyclization of N-Propargyl Enamines. Synthesis. (Mass) 2020, 52, A\u2013I."}, {"Citation": "Sahu PK; Sahu PK; Kaurav MS; Messali M; Almutairi SM; Sahu PL; Agarwal DD Metal-Free Construction of Fused Pyrimidines via Consecutive C-C and C-N Bond Formation in Water. ACS Omega 2018, 3, 15035\u201315042. doi: 10.1021/acsomega.8b01993.", "ArticleIdList": ["10.1021/acsomega.8b01993", "PMC6643823", "31458170"]}, {"Citation": "Gupta PK; Hussain MK; Asad M; Kant R; Mahar R; Shukla SK; Hajela K A Metal-Free Tandem Approach to Prepare Structurally Diverse N-Heterocycles: Synthesis of 1,2,4-Oxadiazoles and Pyrimidinones. New J. Chem 2014, 38, 3062\u20133070. doi: 10.1039/c4nj00361f.", "ArticleIdList": ["10.1039/c4nj00361f"]}, {"Citation": "Tietze LF Domino Reactions: Concepts for Efficient Organic Synthesis; Wiley-VCH, March 2014. ISBN: 978-3-527-33432-2."}, {"Citation": "Bruneau A; Roche M; Alami M; Messaoudi S 2-Aminobiphenyl Palladacycles: The \u201cMost Powerful\u201d Precatalysts in C-C and C-Heteroatom Cross-Couplings. ACS Catal. 2015, 5, 1386\u20131396. doi: 10.1021/cs502011x.", "ArticleIdList": ["10.1021/cs502011x"]}, {"Citation": "Ivanov IC; Angelova VT; Vassilev N; Tiritiris I; Iliev B Synthesis of 4-Aminocoumarin Derivatives with N-Substitutents Containing Hydroxy or Amino Groups. Z. Naturforsch 2013, 68, 1031\u20131040. doi: 10.5560/ZNB.2013-3102.", "ArticleIdList": ["10.5560/ZNB.2013-3102"]}, {"Citation": "Sulaiman Al-Ayed A Synthesis of New Substituted Chromen[4,3-c]Pyrazol-4-Ones and Their Antioxidant Activities. Molecules 2011, 16, 10292\u201310302. doi: 10.3390/molecules161210292.", "ArticleIdList": ["10.3390/molecules161210292", "PMC6264664", "22158652"]}, {"Citation": "Xu Z; Ge J; Wang T; Luo T; Liu H; Yu X Highly Stereoselective Synthesis of 2-Aminobenzylidene Derivatives by a Convergent 3-Component Approach. Synlett. 2014, 25, 2913\u20132917. doi: 10.1055/s-0034-1378906.", "ArticleIdList": ["10.1055/s-0034-1378906"]}, {"Citation": "Vishnu S; Srikanth P; Tiwari AK; Kumar DA; Raju BC\nCarbohydrate Hydrolyzing Enzymes Inhibitory and Free Radical Scavenging Activities of Substituted 2H-Chromene-3-Carboxylates, 2H-Chromenyl Knoevenagel Derivatives and 6H-Chromenoquinolinones. Indian J. Chem\n2015, 54B, 1332\u20131341. http://hdl.handle.net/123456789/33034."}, {"Citation": "Vasbinder MM; Alimzhanov M; Augustin M; Bebernitz G; Bell K; Chuaqui C; Deegan T; Ferguson AD; Goodwin K; Huszar D; Kawatkar A; Kawatkar S; Read J; Shi J; Steinbacher S; Steuber H; Su Q; Toader D; Wang H; Woessner R; Wu A; Ye M; Zinda M Identification of Azabenzimidazoles as Potent JAK1 Selective Inhibitors. Bioorg. Med. Chem. Lett 2016, 26, 60\u201367. doi: 10.1016/j.bmcl.2015.11.031.", "ArticleIdList": ["10.1016/j.bmcl.2015.11.031", "26614408"]}, {"Citation": "Song P; Peng P; Han M; Cao X; Ma X; Liu T;Zhou Y; Hu Y Design, Synthesis and Biological Evaluation of Thienopyridinones as Chk1 Inhibitors. Bioorg. Med. Chem 2014,22, 4882\u20134892. doi: 10.1016/j.bmc.2014.06.044.", "ArticleIdList": ["10.1016/j.bmc.2014.06.044", "25042558"]}, {"Citation": "Pastor J; Oyarzabal J; Saluste G; Alvarez RM; Rivero V; Ramos F; Cend\u00f3n E; Blanco-Aparicio C; Ajenjo N; Cebri\u00e1 A; Albarr\u00e1n MI; Cebri\u00e1n D; Corrionero A; Fominaya J; Montoya G; Mazzorana M Hit to Lead Evaluation of 1,2,3-Triazolo[4,5-b]Pyridines as PIM Kinase Inhibitors. Bioorganic Med. Chem. Lett 2012, 22, 1591\u20131597. doi: 10.1016/j.bmcl.2011.12.130.", "ArticleIdList": ["10.1016/j.bmcl.2011.12.130", "22266039"]}, {"Citation": "Renhowe PA; Pecchi S; Shafer CM; Machajewski TD; Jazan EM; Taylor C; Antonios-McCrea W; McBride CM; Frazier K; Wiesmann M; Lapointe GR; Feucht PH; Warne RL; Heise CC; Menezes D; Aardalen K; Ye H; He M; Le V; Vora J; Jansen JM; Wernette-Hammond ME; Harris AL Design, Structure-Activity Relationships and in Vivo Characterization of 4-Amino-3-Benzimidazol-2-Ylhydroquinolin-2-Ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors. J. Med. Chem 2009, 52, 278\u2013292. doi: 10.1021/jm800790t.", "ArticleIdList": ["10.1021/jm800790t", "19113866"]}, {"Citation": "Silvaa VB; Orth ES Are Imidazoles Versatile or Promiscuous in Reactions with Organophosphates? Insights from the Case of Parathion. J. Braz. Chem. Soc 2019, 30,2114\u20132124."}, {"Citation": "Vyasamudri S; Yang D-Y Base-Dependent Divergent Annulation of 4-Chloro-3-Formyl-Coumarin and Tetrahydroisoquinoline: Application to the Synthesis of Isolamellarins and Hydroxypyrrolones. J. Org. Chem 2019, 84, 3662\u20133670. doi: 10.1021/acs.joc.8b03259.", "ArticleIdList": ["10.1021/acs.joc.8b03259", "30807162"]}, {"Citation": "Angelova VT; Frey W; Ivanov IC; Vassilev N; Glasnov TN One-pot Synthesis of a Chromeno-[4,3,2-de]-1,6-Naphthyridine Derivative from 4-Chlorocoumarin-3-Carbaldehyde. Bulg. Chem. Commun 2014, 46, 53\u201358."}, {"Citation": "Shaabani A; Hooshmand SE Malononitrile Dimer as a Privileged Reactant in Design and Skeletal Diverse Synthesis of Heterocyclic Motifs. Mol. Diversity 2018, 22, 207\u2013224. doi: 10.1007/s11030-017-9807-y.", "ArticleIdList": ["10.1007/s11030-017-9807-y", "29299856"]}, {"Citation": "Yang Z; Lu N; Wei Z; Cao J; Liang D; Duan H; Lin Y Base-Promoted Intermolecular Cyclization of Substituted 3-Aryl(Heteroaryl)-3-Chloroacrylaldehydes and Tetrahydroisoquinolines: An Approach to Access Pyrrolo [2,1-a]Isoquinolines. J. Org. Chem 2016, 87, 11950\u201311955. doi: 10.1021/acs.joc.6b01781.", "ArticleIdList": ["10.1021/acs.joc.6b01781", "27802591"]}, {"Citation": "Sammet B; Bogner T; Nahrwold M; Weiss C; Sewald N Approaches for the Synthesis of Functionalized Cryptophycins. J. Org. Chem 2010, 75, 6953\u20136960. doi: 10.1021/jo101563s.", "ArticleIdList": ["10.1021/jo101563s", "20857920"]}, {"Citation": "Shaaban KA; Elshahawi SI; Wang X; Horn J; Kharel MK; Leggas M; Thorson JS Cytotoxic Indolocarbazoles from Actinomadura Melliaura ATCC 39691. J. Nat. Prod 2015, 78, 1723\u20131729. doi: 10.1021/acs.jnatprod.5b00429.", "ArticleIdList": ["10.1021/acs.jnatprod.5b00429", "PMC4515175", "26091285"]}, {"Citation": "Shaaban KA; Wang X; Elshahawi SI; Ponomareva LV; Sunkara M; Copley GC; Hower JC; Morris AJ; Kharel MK; Thorson JS; Herbimycins D-F Ansamycin Analogues from Streptomyces sp. RM-7\u201315. J. Nat. Prod 2013, 76, 1619\u20131626. doi: 10.1021/np400308w.", "ArticleIdList": ["10.1021/np400308w", "PMC3852429", "23947794"]}, {"Citation": "Wang X; Shaaban KA; Elshahawi SI; Ponomareva LV; Sunkara M; Zhang Y; Copley GC; Hower JC; Morris AJ; Kharel MK; Thorson JS Frenolicins C-G, Pyranonaphthoquinones from Streptomyces sp. RM-4-15. J. Nat. Prod 2013, 76, 1441\u20131447. doi: 10.1021/np400231r.", "ArticleIdList": ["10.1021/np400231r", "PMC3862173", "23944931"]}, {"Citation": "Mokhtari RB; Homayouni TS; Baluch N; Morgatskaya E; Kumar S; Das B; Yeger H Combination Therapy in Combating Cancer. Oncotarget. 2017, 8, 38022\u201338043. doi: 10.18632/oncotarget.16723.", "ArticleIdList": ["10.18632/oncotarget.16723", "PMC5514969", "28410237"]}, {"Citation": "Bai ZG; Zhang ZT A Systematic Review and Meta-Analysis on the Effect of Angiogenesis Blockade for the Treatment of Gastric Cancer. OncoTargets Ther 2018, 11, 7077\u20137087. doi: 10.2147/OTT.S169484.", "ArticleIdList": ["10.2147/OTT.S169484", "PMC6200090", "30410364"]}, {"Citation": "Shaaban M; Yassin FY; Soltan MM Calamusins J-K: new Anti-Angiogenic Sesquiterpenes from Sarcophyton Glaucum. Nat. Prod. Res 2020. in press.", "ArticleIdList": ["33019814"]}, {"Citation": "Khan I; Hatiboglu MA Can COVID-19 Induce Glioma Tumorogenesis Through Binding Cell Receptors? Med. Hypotheses 2020, 144, 110009. doi: 10.1016/j.mehy.2020.110009.", "ArticleIdList": ["10.1016/j.mehy.2020.110009", "PMC7303027", "32758869"]}, {"Citation": "Daina A; Michielin O; Zoete V SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules. Sci. Rep 2017, 7, 42717\u201342730. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Arnott JA; Planey SL The Influence of Lipophilicity in Drug Discovery and Design. Expert Opin. Drug Discov 2012, 7,863\u2013875. doi: 10.1517/17460441.2012.714363.", "ArticleIdList": ["10.1517/17460441.2012.714363", "22992175"]}, {"Citation": "Savjani KT; Gajjar AK; Savjani JK Drug Solubility: Importance and Enhancement Techniques. ISRN. Pharm 2012, 2012, 195727.", "ArticleIdList": ["PMC3399483", "22830056"]}, {"Citation": "Daina A; Michielin O; Zoete V SwissTargetPrediction: Updated Data and new Features for Efficient Prediction of Protein Targets of Small Molecules. Nucleic Acids Res. 2019, 1\u20138.", "ArticleIdList": ["PMC6602486", "31106366"]}, {"Citation": "Vora C; Gupta S Targeted Therapy in Cervical Cancer. ESMO Open 2019, 3, e000462.", "ArticleIdList": ["PMC6438352", "30997156"]}, {"Citation": "Batran RZ; Dawood DH; El-Seginy SA; Ali MM; Maher TJ; Gugnani KS; Rondon-Ortiz AN New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38a MAPK. Arch. Pharm. Chem. Life Sci 2017,350, e1700064. doi: 10.1002/ardp.201700064.", "ArticleIdList": ["10.1002/ardp.201700064", "28787092"]}, {"Citation": "Hsu K; Chen Y; Lin S; Yang J iGEMDOCK: a Graphical Environment of Enhancing GEMDOCK Using Pharmacological Interactions and Post-Screening Analysis. BMC Bioinformatics 2011, 12, S33\u2013S44. doi: 10.1126/science.1101637.", "ArticleIdList": ["10.1126/science.1101637", "PMC3044289", "21342564"]}, {"Citation": "Pao W; Miller V; Zakowski M; Doherty J; Politi K; Sarkaria I; Singh B; Heelan R; Rusch V; Fulton L; Mardis E; Kupfer D; Wilson R; Kris M; Varmus H EGF Receptor Gene Mutations Are Common in Lung Cancers from \u201cNever Smokers\u201d and are Associated with Sensitivity of Tumors to Gefitinib and Erlotinib. Proc. Natl Acad. Sci. USA 2004, 101, 13306\u201313311. doi: 10.1073/pnas.0405220101.", "ArticleIdList": ["10.1073/pnas.0405220101", "PMC516528", "15329413"]}, {"Citation": "Lynch TJ; Bell DW; Sordella R; Gurubhagavatula S; Okimoto RA; Brannigan BW; Harris PL; Haserlat SM; Supko JG; Haluska FG; Louis DN; Christiani DC; Settleman J; Haber DA Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib. N. Engl. J. Med 2004, 350, 2129\u20132139. doi: 10.1056/nejmoa040938.", "ArticleIdList": ["10.1056/nejmoa040938", "15118073"]}, {"Citation": "Halgren TA Merck Molecular Force Field. I. Basis, Form, Scope, Parameterization, and Performance of MMFF94. J. Comput. Chem 1996, 17, 490\u2013519. doi: 10.1002/(SICI)1096-987X(199604).", "ArticleIdList": ["10.1002/(SICI)1096-987X(199604)"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "13", "Hour": "2", "Minute": "9"}, {"Year": "2021", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "2022", "Month": "7", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35821884", "NIHMS1761482", "PMC9273165", "10.1080/17518253.2021.1981462"]}}], "PubmedBookArticle": []}